Literature DB >> 23299303

The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy.

M M Lauridsen1, M Thiele, N Kimer, H Vilstrup.   

Abstract

Existing tests for minimal/covert hepatic encephalopathy (m/cHE) are time- and expertise consuming and primarily useable for research purposes. An easy-to-use, fast and reliable diagnostic and grading tool is needed. We here report on the background, experience, and ongoing research regarding the continuous reaction times (CRT) method. The method has been in clinical use for decades in Denmark for the stated purpose. The method is a 10-minutes, computerised registration of a series of motor reaction times to an auditory stimulus, with results reported as the CRTindex (50 percentile/(90-10) percentile) as a parameter of reaction time variability. The index is a measure of alertness stability and is used to assess attention and cognition deficits. The CRTindex identifies half of patients in a Danish cohort with chronic liver disease, as having m/cHE, a normal value safely precludes HE, it has a broad outcome span reflecting the degree of brain impairment, it shows no learning effect, and it is independent on age and gender. The CRTindex is, therefore, a candidate tool for routine screening, detecting, grading, and monitoring m/cHE. Still, however, further methodological and clinical validation trials are required and are currently being conducted.

Entities:  

Mesh:

Year:  2013        PMID: 23299303     DOI: 10.1007/s11011-012-9373-z

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  24 in total

1.  Normal values of patellar and ankle tendon reflex latencies.

Authors:  C J Frijns; D M Laman; M A van Duijn; H van Duijn
Journal:  Clin Neurol Neurosurg       Date:  1997-02       Impact factor: 1.876

2.  Simple and choice reaction time following severe head injury.

Authors:  E Miller
Journal:  Cortex       Date:  1970-03       Impact factor: 4.027

3.  Fine motor performance in subjects of subnormal, normal and superior intelligence. I. Reaction time and task complexity.

Authors:  I Bankhead; D N MacKay
Journal:  J Ment Defic Res       Date:  1982-06

4.  Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis.

Authors:  Mette Munk Lauridsen; Henning Grønbæk; Esben B Næser; Steffen T Leth; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2012-05-22       Impact factor: 3.584

5.  Transjugular intrahepatic portosystemic shunt does not alter cerebral blood flow.

Authors:  Peter Iversen; Susanne Keiding; Kim Mouridsen; Peter Ott; Hendrik Vilstrup
Journal:  Clin Gastroenterol Hepatol       Date:  2011-07-30       Impact factor: 11.382

Review 6.  Psychometric tests for diagnosing minimal hepatic encephalopathy.

Authors:  Karin Weissenborn
Journal:  Metab Brain Dis       Date:  2012-09-21       Impact factor: 3.584

7.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

8.  Clinical and psychological effects of intravenous diazepam related to plasma levels. A controlled, double-blind, cross-over study in oral surgery involving local analgesia.

Authors:  F Harder; P Elsass; E F Hvidberg; E Hjorting-Hansen; J Hendel
Journal:  Int J Oral Surg       Date:  1976-10

9.  Reaction time deficit in multiple sclerosis.

Authors:  P Elsass; I Zeeberg
Journal:  Acta Neurol Scand       Date:  1983-10       Impact factor: 3.209

10.  Encephalopathy in patients with cirrhosis of the liver. A neuropsychological study.

Authors:  P Elsass; Y Lund; L Ranek
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

View more
  21 in total

Review 1.  Brain edema: a valid endpoint for measuring hepatic encephalopathy?

Authors:  Chantal Bémeur; Cristina Cudalbu; Gitte Dam; Alexander S Thrane; Arthur J L Cooper; Christopher F Rose
Journal:  Metab Brain Dis       Date:  2016-06-07       Impact factor: 3.584

2.  Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.

Authors:  Jasmohan S Bajaj; Douglas M Heuman; Richard K Sterling; Arun J Sanyal; Muhammad Siddiqui; Scott Matherly; Velimir Luketic; R Todd Stravitz; Michael Fuchs; Leroy R Thacker; HoChong Gilles; Melanie B White; Ariel Unser; James Hovermale; Edith Gavis; Nicole A Noble; James B Wade
Journal:  Clin Gastroenterol Hepatol       Date:  2014-05-17       Impact factor: 11.382

Review 3.  Challenges in diagnosing hepatic encephalopathy.

Authors:  K Weissenborn
Journal:  Neurochem Res       Date:  2014-08-21       Impact factor: 3.996

4.  Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathy.

Authors:  M M Lauridsen; L Poulsen; C K Rasmussen; M Høgild; M K Nielsen; O B Schaffalitzky de Muckadell; H Vilstrup
Journal:  Metab Brain Dis       Date:  2015-10-05       Impact factor: 3.584

5.  Cognitive dysfunction and hepatitis C virus infection.

Authors:  Antonio Solinas; Maria Rita Piras; Angelo Deplano
Journal:  World J Hepatol       Date:  2015-05-08

6.  Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests.

Authors:  M M Lauridsen; O B Schaffalitzky de Muckadell; H Vilstrup
Journal:  Metab Brain Dis       Date:  2015-05-29       Impact factor: 3.584

7.  Opposite effects of sleep deprivation on the continuous reaction times in patients with liver cirrhosis and normal persons.

Authors:  Mette Munk Lauridsen; Jesper Frøjk; Ove B Schaffalitzky de Muckadell; Hendrik Vilstrup
Journal:  Metab Brain Dis       Date:  2014-07-10       Impact factor: 3.584

8.  Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study.

Authors:  Sanath Allampati; Andres Duarte-Rojo; Leroy R Thacker; Kavish R Patidar; Melanie B White; Jagpal S Klair; Binu John; Douglas M Heuman; James B Wade; Christopher Flud; Robert O'Shea; Edith A Gavis; Ariel B Unser; Jasmohan S Bajaj
Journal:  Am J Gastroenterol       Date:  2015-12-08       Impact factor: 10.864

9.  In Patients With Cirrhosis, Driving Simulator Performance Is Associated With Real-life Driving.

Authors:  Mette M Lauridsen; Leroy R Thacker; Melanie B White; Ariel Unser; Richard K Sterling; Richard T Stravitz; Scott Matherly; Puneet Puri; Arun J Sanyal; Edith A Gavis; Velimir Luketic; Muhammad S Siddiqui; Douglas M Heuman; Michael Fuchs; Jasmohan S Bajaj
Journal:  Clin Gastroenterol Hepatol       Date:  2015-11-19       Impact factor: 11.382

10.  Determination of Turkish norms of psychometric tests for diagnosing minimal hepatic encephalopathy and proposal of a high sensitive screening test battery.

Authors:  Burak Özbaş; Onur Keskin; Hartmut Hecker; Irfan Karahan; Cansu Özbaş; Çağdaş Kalkan; Aysun Kartal; Fatih Oğuz Önder; Burcu Kahveci Öncü; Genco Gençdal; Murat Akyildiz; Fulya Günşar; Ramazan Idilman; Karin Weissenborn; Ömer Özütemiz; Cihan Yurdaydin
Journal:  Hepatol Int       Date:  2021-06-03       Impact factor: 6.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.